https://www.sciencedaily.com/news/health_medicine/lupus/ Lupus News. Read the latest research on lupus and related autoimmune diseases, including new experimental treatments. en-us Sun, 08 Mar 2026 21:12:48 EDT Sun, 08 Mar 2026 21:12:48 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/lupus/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/03/260303145725.htm Stiff knees and aching hips may seem like an inevitable part of aging, but experts say we’re getting osteoarthritis all wrong. Despite affecting nearly 600 million people worldwide — and potentially a billion by 2050 — the most powerful treatment isn’t surgery or medication. It’s exercise. Movement nourishes cartilage, strengthens muscles, reduces inflammation, and even reshapes the biological processes driving joint damage. Wed, 04 Mar 2026 16:35:02 EST https://www.sciencedaily.com/releases/2026/03/260303145725.htm https://www.sciencedaily.com/releases/2026/02/260219040816.htm A new human study has uncovered how the body naturally turns off inflammation. Researchers found that fat-derived molecules called epoxy-oxylipins rein in immune cells that can otherwise drive chronic disease. Using a drug to boost these molecules reduced pain faster and lowered harmful inflammatory cells. The discovery could pave the way for safer treatments for arthritis, heart disease, and other inflammation-related conditions. Thu, 19 Feb 2026 10:16:55 EST https://www.sciencedaily.com/releases/2026/02/260219040816.htm https://www.sciencedaily.com/releases/2026/02/260204121549.htm Researchers have figured out how psoriasis can quietly turn into joint disease for some patients. Immune cells formed in inflamed skin can travel through the blood and reach the joints, where they sometimes trigger inflammation. The key difference lies in the joint’s ability to keep those cells in check. This insight could help doctors identify warning signs early and prevent lasting joint damage. Thu, 05 Feb 2026 10:44:32 EST https://www.sciencedaily.com/releases/2026/02/260204121549.htm https://www.sciencedaily.com/releases/2026/01/260120000333.htm Scientists at Stanford Medicine have discovered a treatment that can reverse cartilage loss in aging joints and even prevent arthritis after knee injuries. By blocking a protein linked to aging, the therapy restored healthy, shock-absorbing cartilage in old mice and injured joints, dramatically improving movement and joint function. Human cartilage samples from knee replacement surgeries also began regenerating when exposed to the treatment. Tue, 20 Jan 2026 23:55:09 EST https://www.sciencedaily.com/releases/2026/01/260120000333.htm https://www.sciencedaily.com/releases/2025/12/251227082716.htm Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and how that risk might be reduced. They found that the vaccines can spark a two-step immune reaction that floods the body with inflammatory signals, drawing aggressive immune cells into the heart and causing temporary injury. Sat, 27 Dec 2025 10:52:27 EST https://www.sciencedaily.com/releases/2025/12/251227082716.htm https://www.sciencedaily.com/releases/2025/12/251225080723.htm Tramadol, a popular opioid often seen as a “safer” painkiller, may not live up to its reputation. A large analysis of clinical trials found that while it does reduce chronic pain, the relief is modest—so small that many patients likely wouldn’t notice much real-world benefit. At the same time, tramadol was linked to a significantly higher risk of serious side effects, especially heart-related problems like chest pain and heart failure, along with common issues such as nausea, dizziness, and sleepiness. Thu, 25 Dec 2025 11:52:44 EST https://www.sciencedaily.com/releases/2025/12/251225080723.htm https://www.sciencedaily.com/releases/2025/12/251214100940.htm Back pain is wrapped in persistent myths, but many are far from the truth. From misconceptions about heavy lifting and bed rest to confusion over posture, exercise, and surgery, Dr. Meghan Murphy breaks down what really causes pain and what actually helps. Her insights reveal that everyday habits, movement, and smart prevention often make a bigger difference than people realize. Mon, 15 Dec 2025 01:55:23 EST https://www.sciencedaily.com/releases/2025/12/251214100940.htm https://www.sciencedaily.com/releases/2025/12/251214100916.htm SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic osteoarthritis pain while protecting joint tissue. Instead of blocking pain pathways, SN101 uses lab-grown nociceptors that act like sponges, soaking up inflammatory pain factors without sending pain signals. These cells also release regenerative molecules, offering disease-modifying potential that stands apart from traditional corticosteroids and single-target drugs like Nav1.8 inhibitors. Mon, 15 Dec 2025 00:37:44 EST https://www.sciencedaily.com/releases/2025/12/251214100916.htm https://www.sciencedaily.com/releases/2025/11/251126095037.htm Rheumatoid arthritis begins years before pain ever appears, and scientists have now mapped the hidden immune battle that unfolds long before symptoms. By studying people with RA-linked antibodies over seven years, researchers discovered sweeping inflammation, malfunctioning immune cells, and even epigenetic reprogramming in cells that had never encountered a threat. These changes show that the body is preparing for autoimmune attack long before joints become damaged. Wed, 26 Nov 2025 13:01:04 EST https://www.sciencedaily.com/releases/2025/11/251126095037.htm https://www.sciencedaily.com/releases/2025/11/251126095018.htm Researchers at Stanford found a way to cure or prevent Type 1 diabetes in mice using a combined blood stem cell and islet cell transplant. The procedure creates a hybrid immune system that stops autoimmune attacks and eliminates the need for immune-suppressing drugs. The method uses tools already common in clinical practice, putting human trials within reach. Scientists think the same strategy could transform treatments for autoimmune conditions and organ transplantation. Wed, 26 Nov 2025 12:05:21 EST https://www.sciencedaily.com/releases/2025/11/251126095018.htm https://www.sciencedaily.com/releases/2025/11/251117095639.htm Chronic pain might quietly push people toward developing high blood pressure—and the more widespread the pain, the greater the danger. A massive analysis of over 200,000 adults uncovered strong links between long-lasting pain, depression, inflammation, and rising hypertension risk. Mon, 17 Nov 2025 22:42:19 EST https://www.sciencedaily.com/releases/2025/11/251117095639.htm https://www.sciencedaily.com/releases/2025/11/251104013027.htm Using powerful 7-Tesla brain imaging, researchers mapped how the brainstem manages pain differently across the body. They discovered that distinct regions activate for facial versus limb pain, showing the brain’s built-in precision pain control system. The findings could lead to targeted, non-opioid treatments that use cannabinoid mechanisms instead of opioids, offering safer pain relief options. Tue, 04 Nov 2025 05:36:11 EST https://www.sciencedaily.com/releases/2025/11/251104013027.htm https://www.sciencedaily.com/releases/2025/10/251015032316.htm Korean researchers found that low-dose radiation therapy eased knee pain and improved movement in people with mild to moderate osteoarthritis. The treatment, far weaker than cancer radiation, showed real benefits beyond placebo. With no side effects and strong trial results, the approach could provide a middle ground between painkillers and joint surgery. Wed, 15 Oct 2025 10:46:09 EDT https://www.sciencedaily.com/releases/2025/10/251015032316.htm https://www.sciencedaily.com/releases/2025/10/251011043535.htm MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while avoiding attack from the body’s own immune defenses. This innovation could allow doctors to create “off-the-shelf” cancer treatments ready for use immediately after diagnosis, rather than waiting weeks for personalized cell therapies. Sat, 11 Oct 2025 04:35:35 EDT https://www.sciencedaily.com/releases/2025/10/251011043535.htm https://www.sciencedaily.com/releases/2025/10/251009033126.htm Scientists have pinpointed Y1 receptor neurons in the brain that can override chronic pain signals when survival instincts like hunger or fear take precedence. Acting like a neural switchboard, these cells balance pain with other biological needs. The research could pave the way for personalized treatments that target pain at its brain source—offering hope for millions living with long-term pain. Fri, 10 Oct 2025 06:16:16 EDT https://www.sciencedaily.com/releases/2025/10/251009033126.htm https://www.sciencedaily.com/releases/2025/10/251002073959.htm Penn researchers found that psilocybin can calm brain circuits tied to pain and mood, easing both physical suffering and emotional distress in animal studies. The compound works in the anterior cingulate cortex, bypassing injury sites and offering a dual benefit for pain and depression. Unlike opioids, psilocybin is non-addictive and may provide relief lasting weeks. Thu, 02 Oct 2025 09:10:21 EDT https://www.sciencedaily.com/releases/2025/10/251002073959.htm https://www.sciencedaily.com/releases/2025/09/250926035030.htm Scientists have discovered a way to block pain while still allowing the body’s natural healing to take place. Current painkillers like ibuprofen and aspirin often come with harmful side effects because they shut down both pain and inflammation. But this new research identified a single “pain switch” receptor that can be turned off without interfering with inflammation, which actually helps the body recover. Fri, 26 Sep 2025 19:56:30 EDT https://www.sciencedaily.com/releases/2025/09/250926035030.htm https://www.sciencedaily.com/releases/2025/09/250902085154.htm Scientists have decoded the 3D structure of an ancient viral protein hidden in our DNA. The HERV-K Env protein, found on cancer and autoimmune cells, has a unique shape that could unlock new diagnostics and therapies. Wed, 03 Sep 2025 03:54:43 EDT https://www.sciencedaily.com/releases/2025/09/250902085154.htm https://www.sciencedaily.com/releases/2025/08/250826081915.htm Knee osteoarthritis is a major cause of pain and disability, but routine X-rays often do more harm than good. New research shows that being shown an X-ray can increase anxiety, make people fear exercise, and lead them to believe surgery is the only option, even when less invasive treatments could help. By focusing on clinical diagnosis instead, patients may avoid unnecessary scans, reduce health costs, and make better choices about their care. Tue, 26 Aug 2025 09:27:09 EDT https://www.sciencedaily.com/releases/2025/08/250826081915.htm https://www.sciencedaily.com/releases/2025/08/250818102944.htm A sweeping review of 67 trials has cast doubt on the use of ketamine and similar NMDA receptor antagonists for chronic pain relief. While ketamine is frequently prescribed off-label for conditions like fibromyalgia and nerve pain, researchers found little convincing evidence of real benefit and flagged serious side effects such as delusions and nausea. The lack of data on whether it reduces depression or opioid use adds to the uncertainty. Mon, 18 Aug 2025 23:32:20 EDT https://www.sciencedaily.com/releases/2025/08/250818102944.htm https://www.sciencedaily.com/releases/2025/08/250803233101.htm Lupus, a relentless autoimmune disease, appears to mellow with age. While it aggressively targets organs with runaway interferon signaling in younger adults, researchers at UCSF have found that the aging process itself may naturally tone down these immune system attacks. By comparing immune markers across age groups, the team discovered that lupus patients actually show decreasing inflammation as they grow older, in stark contrast to typical “inflammaging.” This surprising twist opens the door to new age-targeted treatments and raises hope for managing not just lupus, but other inflammatory conditions as well. Mon, 04 Aug 2025 04:45:09 EDT https://www.sciencedaily.com/releases/2025/08/250803233101.htm https://www.sciencedaily.com/releases/2025/08/250802022917.htm In a fascinating twist, Mayo Clinic researchers discovered that a sugar molecule cancer cells use to hide from the immune system might also protect insulin-producing beta cells in type 1 diabetes. By engineering these cells with the same sugar molecule—sialic acid—they prevented immune attacks in lab models. This approach could lead to better transplant options without broad immune suppression, offering hope for millions living with the autoimmune disease. Sat, 02 Aug 2025 09:39:45 EDT https://www.sciencedaily.com/releases/2025/08/250802022917.htm https://www.sciencedaily.com/releases/2025/07/250730030358.htm Stepping into a virtual forest or waterfall scene through VR could be the future of pain management. A new study shows that immersive virtual nature dramatically reduces pain sensitivity almost as effectively as medication. Researchers at the University of Exeter found that the more present participants felt in these 360-degree nature experiences, the stronger the pain-relieving effects. Brain scans confirmed that immersive VR scenes activated pain-modulating pathways, revealing that our brains can be coaxed into suppressing pain by simply feeling like we re in nature. Wed, 30 Jul 2025 03:03:58 EDT https://www.sciencedaily.com/releases/2025/07/250730030358.htm https://www.sciencedaily.com/releases/2025/07/250710113151.htm What if your brain is the reason some pain feels unbearable? Scientists at the Salk Institute have discovered a hidden brain circuit that gives pain its emotional punch—essentially transforming ordinary discomfort into lasting misery. This breakthrough sheds light on why some people suffer more intensely than others from conditions like fibromyalgia, migraines, and PTSD. By identifying the exact group of neurons that link physical pain to emotional suffering, the researchers may have found a new target for treating chronic pain—without relying on addictive medications. Thu, 10 Jul 2025 23:37:05 EDT https://www.sciencedaily.com/releases/2025/07/250710113151.htm https://www.sciencedaily.com/releases/2025/06/250623233327.htm A groundbreaking wireless implant promises real-time, personalized pain relief using AI and ultrasound power no batteries, no wires, and no opioids. Designed by USC and UCLA engineers, it reads brain signals, adapts on the fly, and bends naturally with your spine. Tue, 24 Jun 2025 02:38:14 EDT https://www.sciencedaily.com/releases/2025/06/250623233327.htm https://www.sciencedaily.com/releases/2025/06/250603115020.htm Researchers asked patients, some of whom had experienced lower back pain for up to 40 years, if being in nature helped them coped better with their lower back pain. They found that people able to spend time in their own gardens saw some health and wellbeing benefits. However, those able to immerse themselves in larger green spaces such as forests felt even more positive, as they were able to lose themselves in the environment and focus more on that than their pain levels. The researchers have recommended trying to incorporate time spent in nature into people's treatments plans, and are also using their findings to develop virtual reality interventions that allow people to experience some of the benefits of being in nature without the need to travel anywhere if they are unable to do so. Tue, 03 Jun 2025 11:50:20 EDT https://www.sciencedaily.com/releases/2025/06/250603115020.htm https://www.sciencedaily.com/releases/2025/06/250602155330.htm A trial of an interactive game that trains people to alter their brain waves has shown promise as a treatment for nerve pain -- offering hope for a new generation of drug-free treatments. Mon, 02 Jun 2025 15:53:30 EDT https://www.sciencedaily.com/releases/2025/06/250602155330.htm https://www.sciencedaily.com/releases/2025/05/250520121152.htm By studying Chikungunya virus, scientists shed light on how immune responses to viral infections may lead to persistent symptoms of autoimmune disease. Tue, 20 May 2025 12:11:52 EDT https://www.sciencedaily.com/releases/2025/05/250520121152.htm https://www.sciencedaily.com/releases/2025/05/250520121149.htm Middle-aged and older adults who experience pain are more likely to have had worsening symptoms of depression up to eight years before the pain began, according to a new study. Tue, 20 May 2025 12:11:49 EDT https://www.sciencedaily.com/releases/2025/05/250520121149.htm https://www.sciencedaily.com/releases/2025/05/250516134541.htm Psychological treatment can relieve pain. New research now shows what happens in the brain -- and what specific treatments psychologists, doctors and patients can turn to. Fri, 16 May 2025 13:45:41 EDT https://www.sciencedaily.com/releases/2025/05/250516134541.htm https://www.sciencedaily.com/releases/2025/05/250515132451.htm An international research team has discovered a critical protein that acts as a 'switch' regulating immune responses to viruses. Thu, 15 May 2025 13:24:51 EDT https://www.sciencedaily.com/releases/2025/05/250515132451.htm https://www.sciencedaily.com/releases/2025/05/250514180735.htm Some patients with lupus who possess specific antibodies are at a higher risk of thrombotic events such as a blood clot, stroke or heart attack, a new study shows. The finding might help clinicians determine which patients may need early treatment and clinical monitoring for thrombotic events. Wed, 14 May 2025 18:07:35 EDT https://www.sciencedaily.com/releases/2025/05/250514180735.htm https://www.sciencedaily.com/releases/2025/05/250506131322.htm Researchers have created an effective therapy for chronic pain that reduces pain intensity by focusing on emotional regulation. Tue, 06 May 2025 13:13:22 EDT https://www.sciencedaily.com/releases/2025/05/250506131322.htm https://www.sciencedaily.com/releases/2025/05/250501163952.htm After spending years tracing the origin and migration pattern of an unusual type of immune cell in mice, researchers have shown in a new study how activity of 'good' microbes in the gut is linked to rheumatoid arthritis and, potentially, other autoimmune diseases. Thu, 01 May 2025 16:39:52 EDT https://www.sciencedaily.com/releases/2025/05/250501163952.htm https://www.sciencedaily.com/releases/2025/04/250422155830.htm A preclinical study finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity -- two issues that commonly co-occur with alcohol use disorder (AUD). Tue, 22 Apr 2025 15:58:30 EDT https://www.sciencedaily.com/releases/2025/04/250422155830.htm https://www.sciencedaily.com/releases/2025/04/250410130742.htm Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer. Thu, 10 Apr 2025 13:07:42 EDT https://www.sciencedaily.com/releases/2025/04/250410130742.htm https://www.sciencedaily.com/releases/2025/04/250409212542.htm FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient recruitment for the phase 1 trial will begin soon (NCT06913608). The phase 1 clinical trial will evaluate the safety and efficacy of CLBR001 + SWI019 in patients with myositis, systemic sclerosis, lupus and rheumatoid arthritis, with the potential to expand to other indications in the future. Wed, 09 Apr 2025 21:25:42 EDT https://www.sciencedaily.com/releases/2025/04/250409212542.htm https://www.sciencedaily.com/releases/2025/04/250409114710.htm Scientists have rebuilt, in laboratory glassware, the neural pathway that sends information from the body's periphery to the brain, promising to aid research on pain disorders. Wed, 09 Apr 2025 11:47:10 EDT https://www.sciencedaily.com/releases/2025/04/250409114710.htm https://www.sciencedaily.com/releases/2025/04/250408191656.htm Scientists have helped identify a novel drug compound that selectively activates pain-altering receptors in the body, offering a potentially safer alternative to conventional pain medications. Tue, 08 Apr 2025 19:16:56 EDT https://www.sciencedaily.com/releases/2025/04/250408191656.htm https://www.sciencedaily.com/releases/2025/04/250407173105.htm Eight weeks of mindfulness or cognitive behavioral therapy were associated with improved pain, physical function and quality of life and reduced daily opioid dose in adults with chronic low back pain that required treated with daily opioids, according to a new study. This is one of the largest studies to date to evaluate mindfulness and cognitive behavioral therapy as treatment for opioid-treated chronic pain. Mon, 07 Apr 2025 17:31:05 EDT https://www.sciencedaily.com/releases/2025/04/250407173105.htm https://www.sciencedaily.com/releases/2025/03/250321163545.htm New research shows how a specially trained population of immune cells keeps the peace by preventing other immune cells from attacking their own. The study provides a better understanding of immune regulation during infection and could provide a foundation for interventions to prevent or reverse autoimmune diseases. Fri, 21 Mar 2025 16:35:45 EDT https://www.sciencedaily.com/releases/2025/03/250321163545.htm https://www.sciencedaily.com/releases/2025/03/250318175011.htm Scientists have identified a protein in cells that spurs the release of infection-fighting molecules. The protein, whose role in the immune system had not previously been suspected, provides a potential target for therapies that could prevent over-reactive immune responses that are at the root of several debilitating illnesses. Tue, 18 Mar 2025 17:50:11 EDT https://www.sciencedaily.com/releases/2025/03/250318175011.htm https://www.sciencedaily.com/releases/2025/03/250317160418.htm A new study may help to explain why there is an over-representation of women experiencing chronic pain compared to men and why pain medication may not be as effective for women as it is for men. Findings show, male and females develop pain through different means. Mon, 17 Mar 2025 16:04:18 EDT https://www.sciencedaily.com/releases/2025/03/250317160418.htm https://www.sciencedaily.com/releases/2025/03/250314113601.htm When the brain doesn't know what to expect we perceive pain to be worse, a new study shows. The study may help shape more effective ways to manage pain in the future. Fri, 14 Mar 2025 11:36:01 EDT https://www.sciencedaily.com/releases/2025/03/250314113601.htm https://www.sciencedaily.com/releases/2025/03/250313130758.htm Neuroscientists have shown that experiencing nature can alleviate acute physical pain. Surprisingly, simply watching nature videos was enough to relieve pain. Using functional magnetic resonance imaging, the researchers found that acute pain was rated as less intense and unpleasant when watching nature videos -- along with a reduction in brain activity associated with pain. The results suggest that nature-based therapies can be used as promising complementary approaches to pain management. Thu, 13 Mar 2025 13:07:58 EDT https://www.sciencedaily.com/releases/2025/03/250313130758.htm https://www.sciencedaily.com/releases/2025/03/250313130310.htm Study uncovers new insights into pain pathways associated with temporomandibular joint (TMJ) disorders. Using an innovative in vivo imaging tool to capture functional activity in mouse models of TMJ injury and inflammation, the discovery could pave the way for more effective treatments for the millions affected by TMJ-related facial pain. Thu, 13 Mar 2025 13:03:10 EDT https://www.sciencedaily.com/releases/2025/03/250313130310.htm https://www.sciencedaily.com/releases/2025/03/250312165829.htm A recently completed study found that certain terpenes in Cannabis sativa are effective at relieving post-surgical and fibromyalgia pain in preclinical models. Wed, 12 Mar 2025 16:58:29 EDT https://www.sciencedaily.com/releases/2025/03/250312165829.htm https://www.sciencedaily.com/releases/2025/03/250312125003.htm Lupus is an autoimmune disease where the body's immune system attacks its own tissues and organs, causing inflammation and damaging organs. A new study has now shown that the natural active ingredient gluconolactone restores immune regulation, reduces inflammation and could enable targeted therapy with fewer side effects. Wed, 12 Mar 2025 12:50:03 EDT https://www.sciencedaily.com/releases/2025/03/250312125003.htm https://www.sciencedaily.com/releases/2025/03/250310131832.htm A novel analysis of more than 375 published studies concluded that the association between chronic pain and rates of depression and anxiety is staggering. The study found that 40% of adults with chronic pain experienced 'clinically significant depression and anxiety.' Among those most at risk, the analysis showed, were women, younger adults and people with fibromyalgia. Mon, 10 Mar 2025 13:18:32 EDT https://www.sciencedaily.com/releases/2025/03/250310131832.htm https://www.sciencedaily.com/releases/2025/03/250305172222.htm People who take over-the-counter pain relievers after a concussion may recover faster than those who do not take pain relievers, according to a preliminary study. Wed, 05 Mar 2025 17:22:22 EST https://www.sciencedaily.com/releases/2025/03/250305172222.htm https://www.sciencedaily.com/releases/2025/03/250305134928.htm People with Crohn's disease and related joint inflammation linked to immune system dysfunction have distinct gut bacteria or microbiota, with the bacterium Mediterraneibacter gnavus being a potential biomarker, according to new study. Wed, 05 Mar 2025 13:49:28 EST https://www.sciencedaily.com/releases/2025/03/250305134928.htm https://www.sciencedaily.com/releases/2025/03/250305134819.htm Researchers have developed a compound that relieves pain in mice but doesn't affect the brain, thereby avoiding mind-altering side effects and abuse potential. The custom-designed molecule, derived from cannabis, may provide an alternative to opioids for treating chronic pain. Wed, 05 Mar 2025 13:48:19 EST https://www.sciencedaily.com/releases/2025/03/250305134819.htm https://www.sciencedaily.com/releases/2025/03/250304114050.htm A research team has uncovered the neural mechanisms underlying the processing of pain and itch in the anterior cingulate cortex (ACC). This study provides new insights into how the brain distinguishes between these two distinct sensory experiences. Tue, 04 Mar 2025 11:40:50 EST https://www.sciencedaily.com/releases/2025/03/250304114050.htm https://www.sciencedaily.com/releases/2025/03/250303141830.htm A 'chasm of misunderstanding and miscommunication' is often experienced between clinicians and patients, leading to autoimmune diseases such as lupus and vasculitis being wrongly diagnosed as psychiatric or psychosomatic conditions, with a profound and lasting impact on patients, researchers have found. A study involving over 3,000 participants -- both patients and clinicians -- found that these misdiagnoses (sometimes termed 'in your head' by patients) were often associated with long term impacts on patients' physical health and wellbeing and damaged trust in healthcare services. Mon, 03 Mar 2025 14:18:30 EST https://www.sciencedaily.com/releases/2025/03/250303141830.htm https://www.sciencedaily.com/releases/2025/02/250226163244.htm A new study of more than 2,900 patients provides evidence that it's likely best to use as little corticosteroid medicine as possible when treating people who have lupus pericarditis, a common heart complication of the autoimmune disease Systemic Lupus Erythematosus (SLE). Wed, 26 Feb 2025 16:32:44 EST https://www.sciencedaily.com/releases/2025/02/250226163244.htm https://www.sciencedaily.com/releases/2025/02/250225201252.htm The efficient architecture of our joints, which allows our skeletons to be flexible and sturdy, originated among our most ancient jawed fish ancestors, according to a new study. Tue, 25 Feb 2025 20:12:52 EST https://www.sciencedaily.com/releases/2025/02/250225201252.htm https://www.sciencedaily.com/releases/2025/02/250224175741.htm Receptors on B and T cells hint at what the immune system is targeting. An AI approach called Mal-ID developed increases diagnostic accuracy, particularly for autoimmune diseases. Mon, 24 Feb 2025 17:57:41 EST https://www.sciencedaily.com/releases/2025/02/250224175741.htm https://www.sciencedaily.com/releases/2025/02/250221125805.htm Researchers used visual threat manipulation in the virtual reality environment and thermal stimulation to investigate how the brain perceives pain. They found that the brain perceives pain more strongly when the perceived pain is out of alignment with reality. In particular, pain was amplified when unexpected events occurred. Fri, 21 Feb 2025 12:58:05 EST https://www.sciencedaily.com/releases/2025/02/250221125805.htm https://www.sciencedaily.com/releases/2025/02/250220122518.htm With the goal of informing clinician practice, a new study explores the harms and benefits of continuing and of discontinuing the long-term prescription of opioid medicines to adults with chronic pain. Thu, 20 Feb 2025 12:25:18 EST https://www.sciencedaily.com/releases/2025/02/250220122518.htm https://www.sciencedaily.com/releases/2025/02/250219110023.htm War study in Ukraine suggests hydrodissection may reduce pain, opioid use in amputees. Wed, 19 Feb 2025 11:00:23 EST https://www.sciencedaily.com/releases/2025/02/250219110023.htm